Advertisement

Meyka AI - Contribute to AI-powered stock and crypto research platform
Meyka Stock Market API - Real-time financial data and AI insights for developers
Advertise on Meyka - Reach investors and traders across 10 global markets
CH Stocks

METN.SW Metall Zug AG (SIX) at CHF750 ahead of 19 Mar results: monitor cashflow

March 20, 2026
5 min read
Share with:

METN.SW stock trades at CHF750.00 as Metall Zug AG prepares to report earnings on 19 Mar 2026 and investors focus on cash flow and margins. The group shows a strong trailing EPS of 102.36 and a low trailing PE of 7.33, while market cap stands at CHF337500750.00. Volume is light at 66.00 shares today. Ahead of the report we look at valuation, technical signals, Meyka AI grade, and model-based forecasts to highlight what could move the share price when results arrive

Earnings preview: METN.SW stock results and what to expect

Metall Zug announces results the week after 19 Mar 2026, with the next official earnings date set for 23 Mar 2026. We expect questions on operating cash flow, order intake at Medical Devices, and performance in Infection Control. Management commentary on margins and cash conversion will be critical because the company shows negative operating cash flow per share of -18.47 and free cash flow per share of -96.66

Sponsored

Valuation snapshot and fundamentals for METN.SW stock

METN.SW runs a low market multiple versus peers: trailing PE 7.33 and book value per share 1018.44 suggest value but underlying profitability is mixed. EPS is 102.36, dividend per share is 20.00, and price-to-book sits near 0.86. Current ratio is 0.77, signaling working capital pressure. These exact metrics connect directly to price action: the stock trades below its 50-day (CHF807.12) and 200-day (CHF868.90) averages

Meyka AI grade and forecast for METN.SW stock

Meyka AI rates METN.SW with a score of 66.19 out of 100 — Grade B, suggestion: HOLD. This grade factors in S&P 500 and sector comparisons, financial growth, key metrics, and analyst signals. Meyka AI’s forecast model projects monthly CHF703.31, quarterly CHF729.73, and yearly CHF529.07. Versus the current price CHF750.00, the model implies downside of -6.24% (monthly), -2.67% (quarterly), and -29.46% (yearly). Forecasts are model-based projections and not guarantees

Technical setup and trading signals for METN.SW stock

Technicals show short-term weakness. RSI is 26.94 (oversold) and MACD histogram is negative at -4.83, while ATR is 15.73, indicating elevated volatility. Bollinger Bands middle sits at 791.10 with a lower band near 750.59, so today’s CHF750.00 price is testing lower volatility support. On low volume (today 66.00 vs avg 154.00) any earnings surprise could produce outsized moves

Sector context and peer comparison for METN.SW stock

Metall Zug is classified in Industrials (Conglomerates) on the SIX in Switzerland. The Industrials sector average PE is about 27.98, well above Metall Zug’s 7.33, highlighting a valuation gap. Sector profit margins average stronger performance; Metall Zug posts negative operating margin metrics and stretched cash conversion. We track peer order books and medical-device demand as near-term comparators

Risks and catalysts to watch in the METN.SW earnings report

Key catalysts: order intake trends in Medical Devices, margin recovery in Infection Control, and management guidance on capex and dividends. Key risks: continued negative operating cash flow, extended inventory days (170.46), and low current ratio (0.77). Shares outstanding are 450001.00, and the company pays a dividend yield near 2.67%, which investors will weigh against cash flow dynamics

Final Thoughts

Key takeaways for METN.SW stock: the shares trade at CHF750.00 with a low PE of 7.33 and a high trailing EPS of 102.36, but cash flow and working capital weakness complicate the picture. Our Meyka AI grade (Score 66.19/100, Grade B, suggestion HOLD) distances quantitative value from operational strain. Meyka AI’s forecast model projects monthly CHF703.31, quarterly CHF729.73, and yearly CHF529.07, implying short-term downside of -6.24% and deeper potential weakness over 12 months of -29.46% versus today’s price. We see three concrete outcomes from the earnings release: an upbeat cash-flow beat that supports a re-rating, a mixed result that keeps the stock in value territory, or disappointing cash metrics that force multiple compression. For traders, technicals point to an oversold setup but low liquidity raises execution risk. Use the earnings call and guidance on margins and capex to decide whether METN.SW fits a value hold or needs trimming in a diversified portfolio. For live data and tools see our Meyka AI-powered market analysis platform and the company site for filings

FAQs

When does Metall Zug report earnings and what matters most for METN.SW stock?

Metall Zug’s next report is scheduled around 23 Mar 2026. Investors should focus on operating cash flow, margins at Medical Devices and Infection Control, and management guidance because these drive valuation and the METN.SW stock reaction

How does the valuation of METN.SW stock compare with its sector?

METN.SW stock trades at a trailing PE of 7.33, well below the Industrials sector average PE of 27.98. The gap reflects weak cash flow and margin pressures despite a strong EPS number

What is the Meyka AI forecast and implied upside or downside for METN.SW stock?

Meyka AI’s forecast model projects monthly CHF703.31, quarterly CHF729.73, and yearly CHF529.07. Versus today’s CHF750.00, implied moves are down -6.24% (monthly), -2.67% (quarterly), and -29.46% (yearly). Forecasts are not guarantees

Is METN.SW stock a buy for dividend income?

METN.SW pays a dividend per share of 20.00, implying a yield near 2.67%, but operating cash flow and payout ratio are under pressure. Dividend-focused investors should weigh yield versus cash-flow sustainability

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
Meyka Newsletter
Get analyst ratings, AI forecasts, and market updates in your inbox every morning.
~15% average open rate and growing
Trusted by 10,000+ active investors
Free forever. No spam. Unsubscribe anytime.

What brings you to Meyka?

Pick what interests you most and we will get you started.

I'm here to read news

Find more articles like this one

I'm here to research stocks

Ask our AI about any stock

I'm here to track my Portfolio

Get daily updates and alerts (coming March 2026)